Regenerative Peptide Stack · Vascular + Tissue Support · Off-label
BPC-157 & TB-500
The regenerative
peptide stack
BPC-157 and TB-500 are two of the most commonly discussed regenerative peptides in men’s health. Covered together because they are almost always used as a stack — sharing overlapping mechanisms of tissue repair, vascular support, and anti-inflammatory action that complement each other. Neither directly creates erections, but both support the biological foundation that erectile function depends on.
Both peptides have strong animal data and growing clinical interest — but published human trials specifically for men’s sexual health are limited. They are most credibly used as supportive elements in a broader vascular and regenerative health protocol, not as standalone ED treatments.
The two peptides
BPC-157 and TB-500 — what each one does
BPC-157 (Body Protection Compound-157)
A synthetic peptide derived from a protein found naturally in gastric juice. BPC-157 has demonstrated remarkable tissue healing properties in animal studies — accelerating repair of tendons, ligaments, muscle, gut lining, and blood vessels.
Its relevance to sexual health lies primarily in its effects on angiogenesis (new blood vessel formation) and vascular repair. Better penile vascular health means a better foundation for erectile function. BPC-157 also upregulates nitric oxide pathways — the same pathway that PDE5 inhibitors act on downstream.
Notable: BPC-157 appears to be remarkably safe in animal studies — even at high doses — which has contributed to significant interest in its clinical potential.
TB-500 (Thymosin Beta-4)
TB-500 is a synthetic version of Thymosin Beta-4 — a naturally occurring peptide found in virtually every cell in the body. It plays a key role in tissue repair, cell migration, and anti-inflammatory response.
TB-500 promotes angiogenesis, reduces inflammation, and supports repair of vascular smooth muscle — all relevant to the vascular health underpinning erectile function. It also reduces fibrosis (scarring) in damaged tissue, which may be relevant for men with Peyronie’s disease or post-surgical tissue changes.
Often described as complementary to BPC-157 — where BPC-157 focuses more on growth factor signaling, TB-500 focuses more on cell migration and actin regulation.
Shared mechanisms
Why they work well together
BPC-157 and TB-500 are almost always stacked because their mechanisms overlap and complement each other across three key areas relevant to sexual health.
Angiogenesis — new blood vessel formation
Both peptides promote the formation of new blood vessels and support vascular repair. In the penis, healthy microvasculature is the foundation of erectile response — anything that improves penile vascular health improves the environment for erections.
Anti-inflammatory action
Chronic low-grade inflammation is increasingly recognized as a contributor to vascular ED. Both peptides reduce inflammatory signaling in tissue — potentially improving the vascular environment that erectile function depends on.
Tissue repair and regeneration
Both support repair of damaged tissue including smooth muscle, connective tissue, and vascular structures. For men with ED related to tissue damage — post-surgical, post-radiation, or age-related — this regenerative support is directly relevant.
How they’re used
Dosing, administration, and protocols
Both peptides are typically administered by subcutaneous (under-skin) injection, though BPC-157 is also available in oral capsule form — unusual for peptides, which are normally broken down in the gut. The oral bioavailability of BPC-157 makes it a practical option for men who want to avoid injections.
Common protocols involve daily or twice-daily dosing for a defined cycle (typically 4–12 weeks), followed by a rest period. Protocols vary significantly between providers and the evidence base for specific dosing regimens is limited.
These peptides are almost never used as the sole approach to sexual health concerns. They are most sensibly integrated as supportive elements in a broader protocol that includes primary ED treatments (shockwave therapy, PRP, medications) alongside regenerative peptide support.
BPC-157 and TB-500 occupy a gray regulatory area. They are not FDA-approved drugs. In the US they are frequently sold as “research chemicals” — meaning quality, purity, and concentration are not guaranteed by independent oversight.
The safest approach is obtaining them through a licensed physician via a reputable compounding pharmacy that follows cGMP (Current Good Manufacturing Practice) standards. This is more expensive but ensures product quality and appropriate medical supervision.
The enthusiasm around BPC-157 and TB-500 in wellness communities sometimes runs ahead of the actual published evidence in humans. Strong animal data is meaningful — it indicates biological plausibility and safety — but does not equal proven human efficacy. Set realistic expectations and treat these as supportive elements, not primary ED treatments.
Comparison
BPC-157 vs. TB-500 vs. PRP
| Feature | BPC-157 | TB-500 | PRP (P-Shot®) |
|---|---|---|---|
| Primary mechanism | Angiogenesis, growth factor signaling, NO pathway | Cell migration, anti-inflammatory, actin regulation | Platelet growth factor delivery |
| Direct ED effect? | Indirect — vascular support | Indirect — vascular + anti-inflammatory | More direct — targeted penile tissue |
| Route | Subcutaneous injection or oral | Subcutaneous injection | Penile injection |
| Evidence in humans | Limited — mainly animal data | Limited — mainly animal data | More — published clinical studies in ED |
| Autologous? | No — synthetic peptide | No — synthetic peptide | Yes — from your own blood |
| Best used as | Supportive / adjunct therapy | Supportive / adjunct therapy | Primary regenerative ED treatment |
Common questions
Frequently asked questions
Do BPC-157 and TB-500 directly treat ED?
Not directly. Neither peptide acts on penile tissue in the targeted way that PRP or shockwave therapy does. They support the systemic vascular and tissue health that erectile function depends on — which can have indirect positive effects. Think of them as optimizing the environment for erectile health rather than treating ED as a primary intervention.
Why are they always used together?
Their mechanisms are complementary rather than overlapping — BPC-157 is stronger on growth factor signaling and NO pathway effects; TB-500 is stronger on cell migration, actin regulation, and systemic anti-inflammatory action. Together they cover more of the tissue repair and vascular support spectrum than either does alone. The combination is popular in the peptide community and is increasingly discussed in regenerative medicine protocols.
Is oral BPC-157 as effective as injected?
Oral BPC-157 is unusual among peptides because it appears to survive partial digestion and have systemic effects — which is why it was originally studied for gut healing. Whether oral bioavailability matches injected for vascular and systemic effects is not definitively established. Most serious protocols use injectable BPC-157 for systemic applications, with oral used for gut-specific benefits. Discuss with your provider which route makes sense for your specific goals.
Can BPC-157 and TB-500 be combined with PRP or shockwave?
Yes — and this is how they are most sensibly used in a sexual health context. Shockwave therapy or PRP addresses ED more directly at the penile tissue level; BPC-157/TB-500 supports the broader vascular and tissue environment. Running a peptide protocol alongside primary treatments rather than instead of them is a rational approach. Coordinate with your physician to sequence and monitor the full protocol.
Related treatments
More targeted approaches to consider alongside
Find a peptide therapy provider
Search our directory of vetted physicians offering BPC-157, TB-500, and regenerative peptide protocols — or join the forum to hear from men using these treatments.
This page is for informational purposes only and does not constitute medical advice. BPC-157 and TB-500 are not FDA-approved drugs. They are off-label research compounds. Published human clinical trials specifically for sexual health applications are limited. Always work with a licensed physician and obtain peptides from reputable compounding pharmacies. Results vary and are not guaranteed.